OpenAlex
PricingAboutJobs
Log inGet started
Work

A Phase 2 Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy

HTML PDF

Year: 2013
Type: article
Study design: Clinical Trial
Source: Clinical Gastroenterology and Hepatology
DOI: 10.1016/j.cgh.2013.06.021
Authors: Geoffrey M. Forbes, Marian J. Sturm, Rupert W. Leong, Miles P. Sparrow, Dev Segarajasingam, Adrian G. Cummins, Michael Phillips, Richard P. Herrmann
Institutions: The University of Western Australia, Royal Perth Hospital, Concord Repatriation General Hospital, The Alfred Hospital, Sir Charles Gairdner Hospital, Queen Elizabeth Hospital, Harry Perkins Institute of Medical Research
Language: English

Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: allogeneic mesenchymal stromal cells, Crohn's disease, refractory Crohn's disease, biologic failure, infliximab, adalimumab, cell therapy, clinical remission, endoscopic improvement, C-reactive protein, quality of life, safety, CD activity index
SDG: Good health and well-being

Open Access status: bronze

Funders: Eli and Edythe Broad Foundation, Therapeutic Innovation Australia, Fogarty International Center
OpenAlex ID: W2160666118
FWCI: 25.55
Cites: 21
Cited by: 361
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms